AR121012A1 - TRICYCLIC COMPOUNDS AS KRAS INHIBITORS - Google Patents

TRICYCLIC COMPOUNDS AS KRAS INHIBITORS

Info

Publication number
AR121012A1
AR121012A1 ARP210100046A ARP210100046A AR121012A1 AR 121012 A1 AR121012 A1 AR 121012A1 AR P210100046 A ARP210100046 A AR P210100046A AR P210100046 A ARP210100046 A AR P210100046A AR 121012 A1 AR121012 A1 AR 121012A1
Authority
AR
Argentina
Prior art keywords
tricyclic compounds
kras inhibitors
kras
inhibitors
tricyclic
Prior art date
Application number
ARP210100046A
Other languages
Spanish (es)
Inventor
xiaozhao Wang
Wenyu Zhu
Chunhong He
Alexander Sokolsky
Jeffrey Yang
Zhenwu Li
Chao Qi
Yong Li
Pei Gan
Peter Carlsen
Gia Hoang
Liangxing Wu
Wenqing Yao
Original Assignee
Incyte Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Corp filed Critical Incyte Corp
Publication of AR121012A1 publication Critical patent/AR121012A1/en

Links

ARP210100046A 2020-01-10 2021-01-08 TRICYCLIC COMPOUNDS AS KRAS INHIBITORS AR121012A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202062959536P 2020-01-10 2020-01-10

Publications (1)

Publication Number Publication Date
AR121012A1 true AR121012A1 (en) 2022-04-06

Family

ID=81388051

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP210100046A AR121012A1 (en) 2020-01-10 2021-01-08 TRICYCLIC COMPOUNDS AS KRAS INHIBITORS

Country Status (1)

Country Link
AR (1) AR121012A1 (en)

Similar Documents

Publication Publication Date Title
AR119765A1 (en) IMIDAZOLIL PYRIMIDINILAMINE COMPOUNDS AS CDK2 INHIBITORS
CY1123631T1 (en) SUBSTITUTED TRICYCLIC COMPOUNDS AS FGFR INHIBITORS
MA43753A (en) 1-CYANO-PYRROLIDINE DERIVATIVES AS DBU INHIBITORS
AR120184A1 (en) BICYCLIC AMINES AS INHIBITORS OF CDK2
FR24C1009I1 (en) COMPOUNDS USED AS KINASE INHIBITORS
ES2974445T3 (en) Aminopyrimidine derivatives as CTPS1 inhibitors
AR126102A1 (en) TRICYCLIC HETEROCYCLES AS FGFR INHIBITORS
CR20140024A (en) METALOENZYM INHIBITING COMPOUNDS
CR20140106A (en) COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF THE QUINASE C-KIT
UY33925A (en) TRICYCLIC QUINASE INHIBITORS
CR20150018A (en) MACROCYCLIC INHIBITORS OF VIRUS FLAVIVIRIDAE
CR20120659A (en) PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR CANCER TREATMENT
BR112012029405A2 (en) macrocyclic compounds as trk kinase inhibitors
CR20120641A (en) MACROCYCLICAL COMPOUNDS AS QUINASA TRK INHIBITORS
DOP2014000033A (en) AMINOQUINAZOLINS AS QUINASE INHIBITORS
BR112018003812A2 (en) heteroaryl compounds as irak inhibitors and their uses
UY34051A (en) PIRROLOTRIAZINONA DERIVATIVES AS PI3K INHIBITORS
UY34648A (en) AMIDAS AS PIM INHIBITORS
UY34502A (en) ARILOS AND BICYCLIC INHIBITORS OF SODIUM CHANNELS
CU20110159A7 (en) FUSIONATED PYRIMIDINS
EA201692521A1 (en) PYRAZOL COMPOUNDS AND THEIR APPLICATION AS BLOCATORS OF T-TYPE CALCIUM CHANNELS
AR125273A1 (en) SPIROCYCLIC LACTAMS AS JAK2 INHIBITORS V617F
MA55478A (en) BICYCLIC HPK1 INHIBITORS
MA41803A (en) AMINO-INDAZOLES USED AS SODIUM CHANNEL INHIBITORS
MA52891A (en) AZA-INDOLIC DERIVATIVES USED AS RHO-KINASE INHIBITORS

Legal Events

Date Code Title Description
FB Suspension of granting procedure